BioSpace News Archive

Pieris Pharmaceuticals, Inc. today announced that it will host a third quarter 2022 investor call on Wednesday, November 2, 2022 at 8:00 AM EDT to discuss financial results and provide a corporate update.

Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) today announces that the Investigational New Drug (IND) application of ASC10, an oral antiviral drug candidate targeting viral polymerase of monkeypox virus, has been filed with the U.S. Food and Drug Administration (FDA).

Equillium, Inc. today announced data presented at the annual La Jolla Immunology Conference.

InterVenn Biosciences, a clinical technology company leveraging glycoproteomics to transform the future of healthcare, today announced that Erwin Estigarribia has been appointed President and Chief Operating Officer, effective immediately.

Allogene Therapeutics, Inc. today announced that it will report third quarter 2022 financial results on Wednesday, November 2, 2022, after the close of the market.

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report third quarter 2022 financial results after the market close on Monday, November 7, 2022.

Acer Therapeutics Inc. (Nasdaq: ACER) today announced that the US Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Acer’s patent application No. 16/930,208, exclusively licensed from Assistance Publique—Hôpitaux de Paris, for claims related to certain methods of treating vascular Ehlers-Danlos syndrome (vEDS) with celiprolol.

Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the U.S. launch of Biocare Cardiac.

Social and economic factors are causing couples to delay parenthood. It is generally accepted that maternal age is inversely related with fertility and pregnancy outcome.

PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs.